Company Filing History:
Years Active: 2012-2015
Title: **Inventor Dae Woong Jo: Pioneering Macromolecule Transduction Technologies**
Introduction
Dae Woong Jo is a distinguished inventor based in Gwangju, South Korea, recognized for his significant contributions to the field of biotechnology. With a total of three patents to his name, he has made impactful advancements, particularly in the development of macromolecule transduction domains used in biologically active molecules.
Latest Patents
One of Dae Woong Jo's key innovations includes his latest patent titled “Macromolecule transduction domains and methods for identification and uses thereof.” This invention introduces novel macromolecule transduction domain (MTD) peptides that enable the effective traversal of biologically active molecules across cell membranes. Moreover, the patent details polynucleotides encoding these MTD peptides and outlines methods to identify and engineer biologically active molecules with enhanced cell permeability using these MTD peptides. It presents innovative techniques for importing biologically active molecules into cells, showcasing the potential applications of this research in various biotechnological fields.
Career Highlights
Dae Woong Jo is currently affiliated with Procell Therapeutics Inc., where he works alongside notable colleagues such as Jin Sook Kim and Jae Sun Ko. Through his role in Procell Therapeutics, he continues to explore and expand the boundaries of macromolecular research, contributing to the advancement of therapeutic applications that could benefit various medical disciplines.
Collaborations
Throughout his career, Dae Woong Jo has collaborated with fellow researchers and professionals in the biotechnology sector. His teamwork with Jin Sook Kim and Jae Sun Ko at Procell Therapeutics Inc. emphasizes the importance of collaboration in achieving scientific breakthroughs, facilitating the sharing of knowledge and resources crucial for innovative developments in this field.
Conclusion
Dae Woong Jo exemplifies the spirit of innovation in biotechnology, particularly through his work on macromolecule transduction domains. As he continues to advance his research at Procell Therapeutics Inc., he remains a vital figure in the ongoing quest to enhance the delivery and efficacy of biologically active molecules, shaping the future of therapeutic applications.